Recent research points to the importance of a molecule called relaxin-3 in the brain, with effects on various processes and behaviors such as mood, stress, and cognition. Because these are often…
The Society responded to the Leaving the EU: implications and opportunities for science and research inquiry of the House of Commons' Science and Technology Committee. The Committee…
A potent chemotherapy drug can be life saving for children with cancer, but a new review highlights how it can have long-lasting negative effects on the heart. The review, which is published in the…
It can be challenging for regulators to keep up with advances related to medical drugs and devices. A new analysis and editorial published in the British Journal of Clinical Pharmacology provide…
A new study questions the effectiveness of using pictogram message on the labels of anxiety and sleep medications that interfere with driving – an approach this is currently implemented across…
The Society is a global community at the heart of pharmacology, with over 3,500 members from over 60 countries. Our members are the heart of our Society and ensure that we can continue to lead the…
A recent analysis indicates that adding new therapies called anti-PCSK9 antibodies to other lipid-lowering treatments can help patients lower their LDL cholesterol levels. Mutations in the gene that…
A new review examines the potential of antioxidant approaches for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and…
Safety concerns of the concomitant use of clopidogrel with the proton pump inhibitors (PPIs) omeprazole or esomeprazole were published in May 2009 and February 2010 by European regulatory agencies.…
